Moolec Science SA (MLEC) director details ordinary share option grants

Rhea-AI Filing Summary

Moolec Science SA director Abelleyra Llodra Diego Juan has filed a Form 3 reporting direct holdings of share options over ordinary shares. The filing lists three option grants covering 934, 933 and 933 underlying ordinary shares at an exercise price of 7.1400, expiring on 2031-06-30, 2032-06-30 and 2033-06-30. These entries describe existing derivative positions rather than new open‑market purchases or sales.

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Abelleyra Llodra Diego Juan

(Last) (First) (Middle)

5 CHESTER ROAD

(Street)

BICESTER OX261DU

(City) (State) (Zip)

UNITED KINGDOM

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
02/06/2026

3. Issuer Name and Ticker or Trading Symbol
Moolec Science SA [ MLEC ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Ordinary shares	02/06/2026	06/30/2031	Share Option	934	$7.14	D
Ordinary shares	06/30/2027	06/30/2032	Share Option	933	$7.14	D
Ordinary shares	06/30/2028	06/30/2033	Share Option	933	$7.14	D

Explanation of Responses:

	/s/ Diego Juan Abelleyra Llodra	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does Moolec Science SA (MLEC) Form 3 disclose for Abelleyra Llodra Diego Juan?

The Form 3 shows director Abelleyra Llodra Diego Juan’s existing option-based holdings in Moolec Science SA. It lists three share option grants over 934, 933 and 933 ordinary shares at an exercise price of 7.1400, with expirations from 2031-06-30 through 2033-06-30.

Are there any Moolec Science SA (MLEC) insider share purchases or sales in this Form 3?

No explicit insider share purchases or sales appear in this Form 3. The entries are labeled as holdings, detailing option-based derivative positions over ordinary shares, with no buy or sell transaction codes and a neutral net buy/sell direction in the transaction summary.

What stock option terms are reported for Moolec Science SA (MLEC) director in this Form 3?

The filing reports three direct share option positions over ordinary shares, each with an exercise price of 7.1400. The underlying share amounts are 934, 933 and 933, with expiration dates of 2031-06-30, 2032-06-30 and 2033-06-30, respectively.

How many Moolec Science SA (MLEC) shares are covered by the director’s options in this Form 3?

The Form 3 lists options over three blocks of Moolec Science SA ordinary shares: 934, 933 and 933 underlying shares. Each block is tied to a separate option expiring in 2031, 2032 and 2033, all at an exercise price of 7.1400.

Does the Moolec Science SA (MLEC) Form 3 indicate direct or indirect ownership for the reported options?

The Form 3 characterizes all reported option positions as direct ownership. Each transaction entry shows the ownership code "D" and the derivative summary confirms the ownership type as direct, with no separate entities or indirect holding structures referenced in the provided information.